WMT

102.33

+0.1%↑

PG

159.59

+0.32%↑

KO

67.95

+0.79%↑

PM

164.75

+1.4%↑

PEP

143.14

+1.04%↑

WMT

102.33

+0.1%↑

PG

159.59

+0.32%↑

KO

67.95

+0.79%↑

PM

164.75

+1.4%↑

PEP

143.14

+1.04%↑

WMT

102.33

+0.1%↑

PG

159.59

+0.32%↑

KO

67.95

+0.79%↑

PM

164.75

+1.4%↑

PEP

143.14

+1.04%↑

WMT

102.33

+0.1%↑

PG

159.59

+0.32%↑

KO

67.95

+0.79%↑

PM

164.75

+1.4%↑

PEP

143.14

+1.04%↑

WMT

102.33

+0.1%↑

PG

159.59

+0.32%↑

KO

67.95

+0.79%↑

PM

164.75

+1.4%↑

PEP

143.14

+1.04%↑

Search

USANA Health Sciences Inc

Закрыт

30.28 -1.91

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

30.28

Макс.

30.88

Ключевые показатели

By Trading Economics

Доход

365K

9.7M

Продажи

-14M

236M

P/E

Средняя по отрасли

17.183

31.444

Прибыль на акцию

0.73

Рентабельность продаж

4.094

Сотрудники

1,700

EBITDA

1.3M

29M

Дивиденды

By Dow Jones

Следующий отчет о доходах

21 окт. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

1.1M

565M

Предыдущая цена открытия

32.19

Предыдущая цена закрытия

30.28

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

USANA Health Sciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

9 сент. 2025 г., 23:37 UTC

Популярные акции

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 сент. 2025 г., 20:41 UTC

Отчет

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 сент. 2025 г., 20:30 UTC

Отчет

GameStop 2Q Sales, Profit Rise

9 сент. 2025 г., 23:19 UTC

Обсуждения рынка

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 сент. 2025 г., 21:35 UTC

Отчет

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 21:32 UTC

Отчет

Oracle's Backlog Swells With Big Customer Deals -- Update

9 сент. 2025 г., 21:02 UTC

Приобретения, слияния, поглощения

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 сент. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

9 сент. 2025 г., 20:33 UTC

Отчет

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 сент. 2025 г., 20:26 UTC

Отчет

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 20:23 UTC

Отчет

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 20:12 UTC

Отчет

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 сент. 2025 г., 20:10 UTC

Отчет

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 сент. 2025 г., 20:10 UTC

Отчет

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 сент. 2025 г., 20:09 UTC

Отчет

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 сент. 2025 г., 20:09 UTC

Отчет

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 сент. 2025 г., 20:07 UTC

Отчет

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 сент. 2025 г., 20:06 UTC

Отчет

Oracle 1Q Software Revenue $5.72B >ORCL

9 сент. 2025 г., 20:06 UTC

Отчет

Synopsys 3Q Adj EPS $3.39 >SNPS

9 сент. 2025 г., 20:06 UTC

Отчет

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Rev $14.93B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q EPS $1.01 >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Synopsys 3Q EPS $1.50 >SNPS

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Services Revenue $1.35B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Adj EPS $1.47 >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Hardware Revenue $670M >ORCL

Сравнение c конкурентами

Изменение цены

USANA Health Sciences Inc Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.405 / 29.84Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat